Research Correspondence

DOI: 10.4244/EIJ-D-24-01048

Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation

Yohanna John Zendo1, MD; Santiago Ordoñez1, MD; Michael W.A. Chu1, MD; Matthew Valdis1, MD; Siobhan Molloy1, MN-NP; Mosa Abbadi1, MD; Patrick Teefy1, MD; Pantelis Diamantouros1, MD; Rodrigo Bagur1, MD, PhD

Early discharge (ED) and next-day discharge (NDD) pathways following transfemoral (TF) transcatheter aortic valve implantation (TAVI) have been gaining acceptance among Heart Teams123. We recently demonstrated the safety and feasibility of NDD following TAVI with three different types of commercially available transcatheter heart valves3. However, there is a lack of data on ED and NDD in patients undergoing TAVI using alternative access (A-TAVI). Therefore, this research assessed the safety of an ED/NDD pathway in patients who underwent A-TAVI.

Data from consecutive, all-comers patients who underwent elective A-TAVI between July 2018 and November 2024 were prospectively collected in a dedicated database. Patients followed a fast-track anaesthesia pathway consisting of extubation in the hybrid operating room, 1-hour recovery in the post-anaesthesia care unit, and transfer to the inpatient ward, similar to TF-TAVI under conscious sedation23. Mobilisation was promptly encouraged within four hours following the completion of the procedure, and a transthoracic echocardiogram was performed the following morning. Patients had an electrocardiogram (ECG) shortly after TAVI and again the following day. To qualify for the NDD pathway,...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 12
Jun 16, 2025
Volume 21 Number 12
View full issue


Key metrics

Suggested by Cory

Research Correspondence

10.4244/EIJ-D-24-01048 May 21, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y et al

Editorial

10.4244/EIJ-E-24-00056 Dec 16, 2024
Is next-day discharge after uncomplicated transcatheter aortic valve implantation the new standard of care?
Costa G and Sammartino S
free

Original Research

10.4244/EIJ-D-24-00514 Dec 16, 2024
Readmissions after next-day discharge following transcatheter aortic valve implantation
Bagur R et al

10.4244/EIJV13I8A135 Oct 20, 2017
Day case TAVI: is this a reality?
Jabbour R et al
free

EXPERT REVIEW

10.4244/EIJ-D-18-00552 Sep 7, 2018
Current state of alternative access for transcatheter aortic valve implantation
Lanz J et al
free

10.4244/EIJV15I2A25 Jun 20, 2019
Discharge after TAVI: it can be fast
van Wiechen M et al
free
Trending articles
310.93

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
172.13

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
91.35

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved